Avalon Globocare Corp (CHGA) Stock Analysis

Verdict: AVOID

Severe liquidity strain with <1 month cash runway outweighs speculative AI defense pivots — severe dilution or insolvency risks dominate.

Investment score: 16/100

Analysis as of

Is Avalon Globocare Corp stock worth reviewing? AI model thesis

The AI model maintains an AVOID recommendation on Change Agents Corporation (CHGA). Despite a 9.10% price bounce driven by news of its Seagate partnership, the company's fundamentals reflect severe financial distress, highlighted by $0 revenue in 2025, a cash runway under 1 month, and a current ratio of 0.38x.

7-factor investment score

Avalon Globocare Corp opportunities and risks

What speaks for CHGA

What speaks against CHGA

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CHGAn/a0.0xn/a0.0%0.0%-14.1%
GYRO0.0x0.0x1372.6x0.0%0.0%0.0%
HOOB19.0x3.3x8.2x87.6%17.2%4.7%
ZDPYn/a1.5xn/a68.8%-72.0%16886.1%
GBRn/a25.1xn/a74.5%-56.1%-1.3%
TUXSn/a0.0x0.0x0.0%0.0%-0.0%
Peer mediann/a1.5x0.0x68.8%0.0%0.0%

Frequently asked questions about Avalon Globocare Corp (CHGA)

Is CHGA stock a good investment?

The cached TradeMates AI model rates Avalon Globocare Corp as AVOID with an investment score of 16/100. The AI model maintains an AVOID recommendation on Change Agents Corporation (CHGA). Despite a 9.10% price bounce driven by news of its Seagate partnership, the company's fundamentals reflect severe financial distress, highlighted by $0 revenue in 2025, a cash runway under 1 month, and a current ratio of 0.38x. This is algorithmic model output, not personal investment advice.

Is CHGA stock a buy?

The TradeMates model verdict for CHGA is AVOID with an investment score of 16/100. Treat this as a model signal to review, not a personal buy recommendation.